Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an Acute anterior uveitis cohort

Molecular Vision

Volumn 15, Issue , 2009, Pages 208-212

  Martin, Tammy M ^a   Bye, Louise ^b   Modi, Neil ^b   Stanford, Miles R ^b   Vaughan, Robert ^b   Smith, Justine R ^a   Wade, N Kevin ^c   Mackensen, Friederike ^d   Suhler, Eric B ^a,e   Rosenbaum, James T ^a   Wallace, Graham R ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Kerrisdale Professional Centre   (Canada)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e PORTLAND VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOSINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GUANOSINE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE TYPE 22; THREONINE; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE; SINGLE NUCLEOTIDE POLYMORPHISM; UVEITIS; VISUAL SYSTEM EXAMINATION;

ACUTE DISEASE; ANTIGENS, CD; AUTOIMMUNITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; UVEITIS, ANTERIOR;

EID: 59349110453     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Smith JR. HLA-B27 associated uveitis. Ophthalmol Clin North Am 2002; 15:297-307.
2. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol 2005; 50:364-88.
3. Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 2005; 204:102-15.
4. Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature 2005; 435:584-9.
5. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 2004; 36:337-8.
6. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, Nika K, Tautz L, Tasken K, Cucca F, Mustelin T, Bottini N. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37:1317-9.
7. Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006; 18:214-23.
8. Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune disease. Semin Immunol 2006; 18:207-13.
9. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 of exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000; 165:6606-11.
10. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and type 1 diabetes mellitus. J Clin Endocrinol Metab 1997; 82:143-6.
11. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32:538-41.
12. Tapirdamaz O, Pravica V, Metsaelaar HJ, Hansen B, Moons L, van Meurs JB, Hutchinson IV, Shaw J, Agarwal K, Adams DH, Day CP, Kwekkeboom J. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Gut 2006; 55:863-8.
13. Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens 2008; 72:49-53.
14. Fernandez-Melon J, Muñoz-Fernández S, Hidalgo V, Bonilla-Hernán G, Schlincker A, Fonseca A, Vieitez J, Martín-Mola E. Uveitis as the initial clinical manifestation in patients with spondyloarthropathies. J Rheumatol 2004; 31:524-7.
15. Sampaio-Barros PD, Conde RA, Bonfiglioli R, Bertolo MB, Samara AM. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 2006; 26:1143-6.
16. Natkunarajah M, Kaptoge S, Edelsten C. Risks of relapse in patients with acute anterior uveitis. Br J Ophthalmol 2007; 91:330-4.
17. Otasevic L, Zlatanovic G, Stanojevic-Paovic A, Miljkovic-Selimovic B, Dinic M, Djordjevic-Jocic J, Stankovic A. Helicobacter pylori; an underestimated factor in acute anterior uveitis and spondyloarthopathies. Ophthalmologica 2007; 221:6-13.
18. Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function, but not polymorphisms are associated with acute anterior uveitis. Invest Ophthalmol Vis Sci 2007; 48:1711-7.
19. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006; 3:e297.
20. El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N, Hermann J. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology 2006; 113:695-700.
21. Kuo NW, Lympany PA, Menezo V, Lagan AL, John S, Yeo TK, Liyanage S, du Bois RM, Welsh KI, Lightman S. TNF -857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005; 46:1565-71.
22. El-Shabrawi Y, Hermann J. Anti-tumour necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leucocyte antigen B27-associated acute anterior uveitis. Ophthalmology 2002; 109:2342-6.
23. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 2005; 52:2447-51.
24. Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Hermann J, Ardjomand N, Haller-Schober EM, El-Shabrawi Y. Role of CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B-27 associated uveitis. Mol Vis 2005; 11:896-900.
25. Bowness P. HLA-B27 in health and disease: a double-edged sword. Rheumatology 2002; 41:857-68.
26. Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, Coffman JE, Smith JR, Becker MD, Mackensen F, Khan MA, Levinson RD, Schumacher HR, Wade NK, Rosenbaum JT, Reveille JD. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005; 52:269-74.
27. Du L, Yang P, Hou S, Lin X, Zhou H, Huang X, Wang L, Kiljstra A. Association of the CTLA-4 gene with Vogt-Koyangi-Harada syndrome. Clin Immunol 2008; 127:43-8.
28. Spriewald BM, Lefter C, Huber I, Lauer B, Wenkel H. A suggestive association of Fuch's heterochromic cyclitis with cytotoxic T cell antigen 4 polymorphism. Ophthalmic Res 2007; 39:116-20.